Insiders · MRKR

MRKR insider transactions

Marker Therapeutics Inc. (MRKR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MRKR

• 212d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 212d
  SEC Form 4 filed by Director Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 212d
  SEC Form 4 filed by Director Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 227d
  SEC Form 4 filed by Director Corzo Kathryn Penkus

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 227d
  SEC Form 4 filed by Chief Executive Officer Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 227d
  SEC Form 3 filed by new insider Corzo Kathryn Penkus

  3 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by Director Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 490d
  SEC Form 4 filed by President and CEO Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 540d
  Director Elms Steve bought $35,472 worth of shares (11,085 units at $3.20) (SEC Form 4)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 543d
  Large owner New Enterprise Associates 16, L.P. bought $1,773,600 worth of shares (554,250 units at $3.20) (SEC Form 4)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1080d
  SEC Form 3 filed by new insider Lurier Eliot M

  3 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Wilson John Robert

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1107d
  SEC Form 4 filed by Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1135d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Hoang Tsvetelina P

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Koneru Mythili

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Loiacono Michael

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Szymanska Anna

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1206d
  SEC Form 4 filed by Agopyan Nadia

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Elms Steve

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Wilson John Robert

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Laskow-Pooley David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Eansor Norman David

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1485d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Hoang Peter L. was granted 199,094 shares and covered exercise/tax liability with 48,376 shares, increasing direct ownership by 45% to 483,286 units to satisfy tax liability

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Vera Juan was granted 140,823 shares and covered exercise/tax liability with 33,465 shares, increasing direct ownership by 4% to 2,671,845 units (withholding obligation)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1544d
  SEC Form 4: Kim Anthony H. was granted 150,512 shares and covered exercise/tax liability with 36,076 shares to satisfy withholding tax

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Hoang Peter L.

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Szymanska Anna

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Vera Juan

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Koneru Mythili

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Loiacono Michael

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Kim Anthony H.

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Hoang Tsvetelina P

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Garrett Gerald

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1578d
  SEC Form 4 filed by Agopyan Nadia

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1653d
  SEC Form 4 filed by Knobil Katharine

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1653d
  SEC Form 3: New insider Knobil Katharine claimed ownership of 1,500 shares

  3 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Wasserman Frederick Gerald was granted 12,658 units of Common Stock, increasing direct ownership by 24% to 65,223 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Laskow-Pooley David was granted 12,658 units of Common Stock, increasing direct ownership by 30% to 55,223 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: ELMS STEVE was granted 12,658 units of Common Stock, increasing direct ownership by 74% to 29,680 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Eansor Norman David was granted 12,658 units of Common Stock, increasing direct ownership by 52% to 36,940 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1835d
  SEC Form 4: Wilson John Robert was granted 12,658 units of Common Stock, increasing direct ownership by 0.16% to 7,812,008 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1856d
  SEC Form 4: Wasserman Frederick Gerald bought $24,098 worth of Common Stock (10,000 units at $2.41), increasing direct ownership by 23% to 52,565 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Edward Paul Walker bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: W. Peter Sonsini bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: D Scott Sandell bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Joshua Makower bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Mohamad Makhzoumi bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Jr. A. Anthony Florence bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Carmen Chang bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Ali Behbahani bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Forest Baskett bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: L.P. 16, Associates Enterprise New bought $9,999,999 worth of Common Stock (5,714,285 units at $1.75)

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)
• 1919d
  SEC Form 4: Robert John Wilson bought $2,999,999 worth of Common Stock (1,714,285 units at $1.75), increasing direct ownership by 28% to 7,799,350 units

  4 - Marker Therapeutics, Inc. (0001094038) (Issuer)